|
WO2010068947A2
|
|
Nuclear export inhibitors of topoisomerase ii alpha
|
|
US2010076786A1
|
|
Computer System and Computer-Implemented Method for Providing Personalized Health Information for Multiple Patients and Caregivers
|
|
WO2010002911A2
|
|
Methods and materials for monitoring myeloma using quantitative mass spetrometry
|
|
WO2009135000A2
|
|
Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-117199 and analogs
|
|
WO2009117566A1
|
|
Chemokine gene-modified cells for cancer immunotherapy
|
|
WO2009105746A2
|
|
Triazoles and processes for producing the same
|
|
WO2009039479A1
|
|
Genotypic tumor progression classifier and predictor
|
|
US2008113360A1
|
|
Melanoma gene signature
|
|
WO2006071812A2
|
|
Platinum iv complex inhibitor
|
|
WO2005116890A1
|
|
Computer systems and methods for providing health care
|
